Solid Biosciences Snags Bullish Initiation As It Develops Gene Therapy For Muscular Dystrophy

By: via Benzinga
The young biotech firm Solid Biosciences Inc (NASDAQ: SLDB)secured two Buy ratings Tuesday and another Wednesday. The ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.